J. Goldman & Co LP - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 160 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$2,343,000
-83.3%
267,801
-67.9%
0.18%
-81.5%
Q3 2018$14,026,000
-18.8%
834,926
+1.3%
0.98%
+10.0%
Q2 2018$17,278,000
+127.3%
824,338
+74.5%
0.89%
+175.3%
Q1 2018$7,601,000
-22.6%
472,436
-8.8%
0.32%
-37.1%
Q4 2017$9,816,000
+277.1%
517,979
+180.0%
0.52%
+293.1%
Q3 2017$2,603,000
+581.4%
184,975
+193.6%
0.13%
+445.8%
Q1 2015$382,00063,0000.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders